206 related articles for article (PubMed ID: 6863926)
1. Monoclonal antibodies directed against mouse macrophages in different stages of activation for tumor cytotoxicity.
Taniyama T; Tokunaga T
J Immunol; 1983 Aug; 131(2):1032-7. PubMed ID: 6863926
[TBL] [Abstract][Full Text] [Related]
2. Functionally different subpopulations of mouse macrophages recognized by monoclonal antibodies.
Sun D; Lohmann-Matthes ML
Eur J Immunol; 1982 Feb; 12(2):134-40. PubMed ID: 6978817
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a hybridoma secreting a monoclonal antibody specific for activated tumoricidal macrophages.
Taniyama T; Watanabe T
J Exp Med; 1982 Oct; 156(4):1286-91. PubMed ID: 7153713
[TBL] [Abstract][Full Text] [Related]
4. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
[TBL] [Abstract][Full Text] [Related]
5. Specific surface antigens expressed on activated mouse peritoneal macrophages and recognized by a novel monoclonal antibody.
Someya A
Immunology; 1985 Dec; 56(4):683-8. PubMed ID: 3908293
[TBL] [Abstract][Full Text] [Related]
6. Cell surface antigens on the guinea-pig macrophage: identification by monoclonal antibodies and association with the activation state.
Mauer-Gross U; von Steldern D; Hadding U; Bitter-Suermann D; Burger R
Immunology; 1985 Jul; 55(3):519-30. PubMed ID: 3874819
[TBL] [Abstract][Full Text] [Related]
7. A novel rat monoclonal antibody reactive with murine tumoricidal Kupffer cells and activated peritoneal macrophages from BCG-infected mice.
Someya A
Immunology; 1986 Apr; 57(4):605-10. PubMed ID: 2420709
[TBL] [Abstract][Full Text] [Related]
8. Functional diversity of Ia epitopes on macrophages.
Kedar I; Steinberg AD
Eur J Immunol; 1987 Jul; 17(7):915-9. PubMed ID: 2440695
[TBL] [Abstract][Full Text] [Related]
9. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
[TBL] [Abstract][Full Text] [Related]
10. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
11. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
[TBL] [Abstract][Full Text] [Related]
12. An anti-mouse macrophage monoclonal antibody reacting with T-derived leukaemic cells.
Martin A; Chevrinais AM; Bourel D; Fauchet R; Genetet B; Toujas L
Immunology; 1984 Jul; 52(3):539-46. PubMed ID: 6204931
[TBL] [Abstract][Full Text] [Related]
13. Surface antigens on mouse natural killer cells: use of monoclonal antibodies to inhibit or to enrich cytotoxic activity.
Seaman WE; Talal N; Herzenberg LA; Herzenberg LA; Ledbetter JA
J Immunol; 1981 Sep; 127(3):982-6. PubMed ID: 6790624
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumor effects of BCG and monoclonal antibodies capable of inducing antibody-dependent cell-mediated cytotoxicity.
Komuta K; Kawase I; Ogura T; Masuno T; Yokota S; Hosoe S; Ikeda T; Shirasaka T; Kishimoto S
Jpn J Cancer Res; 1987 Feb; 78(2):185-92. PubMed ID: 3104261
[TBL] [Abstract][Full Text] [Related]
15. Natural killer activity in the peritoneal exudates of mice infected with Listeria monocytogenes: characterization of the natural killer cells by using a monoclonal rat anti-murine macrophage antibody (M1/70).
Holmberg LA; Springer TA; Ault KA
J Immunol; 1981 Nov; 127(5):1792-9. PubMed ID: 6795262
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody-dependent murine macrophage-mediated cytotoxicity against human tumors is stimulated by lentinan.
Herlyn D; Kaneko Y; Powe J; Aoki T; Koprowski H
Jpn J Cancer Res; 1985 Jan; 76(1):37-42. PubMed ID: 3918909
[TBL] [Abstract][Full Text] [Related]
17. The third component of complement (C3) bound to tumor target cells enhances their sensitivity to killing by activated macrophages.
Bara S; Lint TF
J Immunol; 1987 Feb; 138(4):1303-9. PubMed ID: 3100634
[TBL] [Abstract][Full Text] [Related]
18. In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes.
Seto M; Takahashi T; Nakamura S; Matsudaira Y; Nishizuka Y
Cancer Res; 1983 Oct; 43(10):4768-73. PubMed ID: 6192909
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of experimental tumor metastasis by selective activation of natural killer cells.
Hanna N
Cancer Res; 1982 Apr; 42(4):1337-42. PubMed ID: 6277482
[TBL] [Abstract][Full Text] [Related]
20. Similarities in function between pancreatic tumor cells and macrophages and their inhibition by murine monoclonal antibodies.
Schorlemmer HU; Bosslet K; Kern HF; Sedlacek HH
Behring Inst Mitt; 1988 Apr; (82):240-64. PubMed ID: 3408453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
